NACI Updated Statement on the use of Rotavirus Vaccines - July 2010

An article from the "Canada Communicable Disease Report" (CCDR) Volume 36 • ACS-4, July 2010.

The Canada Communicable Disease Report presents current information on infectious diseases for surveillance purposes.

This statement provides an update on the recommendations for use of pentavalent human-bovine reassortant rotavirus vaccine (RotaTeq®) and provides information on the safety, efficacy, and recommended use of live, attenuated monovalent human rotavirus vaccine (Rotarix™).

Source: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/10vol36/acs-4/index-eng.php